- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Vascular Endothelial Growth Factor Overexpression in United States
Total 171 results
-
University of Illinois at Urbana-ChampaignRosenfeld Heart Foundation GrantUnknownCardiovascular Risk Factor | Uncontrolled HypertensionUnited States
-
The Cleveland ClinicNational Eye Institute (NEI)RecruitingRetinal Diseases | Retinal Detachment | Epiretinal Membrane | Fuchs Endothelial Dystrophy | Macular HoleUnited States
-
University of Colorado, DenverNational Heart, Lung, and Blood Institute (NHLBI)RecruitingMyocardial Ischemia | Critical Illness | Endothelial DysfunctionUnited States
-
Johns Hopkins UniversityNational Heart, Lung, and Blood Institute (NHLBI)CompletedHypertension | Sleep | Prehypertension | Endothelial Dysfunction | Overweight and Obesity | Vascular Stiffness | Elevated Blood PressureUnited States
-
Jonsson Comprehensive Cancer CenterNational Center for Advancing Translational Sciences (NCATS)RecruitingGlioblastoma Multiforme | Epidermal Growth Factor Receptor | Glycolytic IndexUnited States
-
Joel TrinityNational Heart, Lung, and Blood Institute (NHLBI)RecruitingAging | Oxidative Stress | Skeletal Muscle | Vascular Endothelium | AntioxidantsUnited States
-
Dana-Farber Cancer InstituteAstellas Pharma IncTerminatedNon-Small Cell Lung Cancer | Epidermal Growth Factor ReceptorUnited States
-
Vanderbilt University Medical CenterNational Heart, Lung, and Blood Institute (NHLBI)RecruitingVascular Diseases | Endothelial Dysfunction | Kidney Injury | Brain Disease | Vascular InflammationUnited States
-
K.Lance GouldGilead SciencesCompletedCoronary Artery Disease | Endothelial DysfunctionUnited States
-
AmgenRecruitingSolid TumorsCanada, Korea, Republic of, Australia, Netherlands, United States, Israel, Austria, Spain, United Kingdom, France, Belgium, Japan, Czechia, Hungary, Poland, Brazil, Argentina, Denmark, Greece, Mexico, Switzerland, Romania, Italy, Finland and more
-
Astellas Pharma Global Development, Inc.Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedAdvanced Breast Cancer | HER2 Amplified | Human Epidermal Growth Factor Receptor 2 (HER2)United States, Belgium, Canada, Italy, Spain, United Kingdom
-
ORA, Inc.CompletedAge-related Macular Degeneration | Age FactorUnited States
-
Tufts UniversityBoston UniversityCompletedCardiovascular Diseases | Hypertension | Heart Disease | Endothelial Dysfunction | Vascular DiseaseUnited States
-
University of Colorado, DenverRecruitingEndothelial Dysfunction | Vascular Stiffness | Insulin Sensitivity/Resistance | TransgenderismUnited States
-
Emmanouil BrilakisCompletedCoronary Artery Disease | Endothelial DysfunctionUnited States
-
University of South CarolinaCompletedPre-Eclampsia | Intrauterine Growth Restriction | Hypertension in Pregnancy | Pre-TermUnited States
-
University of Illinois at Urbana-ChampaignFederal Emergency Management AgencyCompletedCardiovascular Risk Factor | C.Medical Procedure; Vascular, Functional or Late | Electrolyte and Fluid Balance ConditionsUnited States
-
M.D. Anderson Cancer CenterNot yet recruitingHormone Receptor-positive Human Epidermal Growth Factor 2-negative | Metastatic Invasive LObular CarcinomaUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedCoronary Artery Disease | Inflammation | Atherosclerosis | Endothelial DysfunctionUnited States
-
Montefiore Medical CenterAlbert Einstein College of Medicine; Deciphera Pharmaceuticals LLCTerminatedBreast Cancer | Stage IV Breast Cancer | Recurrent Breast Carcinoma | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Breast AdenocarcinomaUnited States
-
University of California, San FranciscoTerminatedPeripheral Arterial Disease | Metabolic Syndrome | Insulin Resistance | Endothelial DysfunctionUnited States
-
Daiichi SankyoAvailableEpidermal Growth Factor Receptor (EGFR)-Mutated Non Small Cell Lung CancerUnited States
-
University of ArizonaNational Cancer Institute (NCI)CompletedMale Breast Cancer | Stage IV Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of BreastUnited States
-
MedSIRPfizerCompletedBreast Cancer | Advanced Breast Cancer | Hormone Receptor Positive Tumor | Human Epidermal Growth Factor 2 Negative Carcinoma of BreastSpain, Germany, France, United Kingdom, Italy, Slovenia
-
Oana Danciu, MDPfizer; Big Ten Cancer Research ConsortiumActive, not recruitingMetastatic Breast Cancer | Hormone Receptor Positive Malignant Neoplasm of Breast | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Estrogen Receptor Positive Breast Cancer | Progesterone Receptor Positive TumorUnited States
-
Northwestern UniversityNational Cancer Institute (NCI); Boehringer Ingelheim; Robert H. Lurie Cancer...Active, not recruitingRecurrent Adult Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Acute Myeloid Leukemia With t(9;11)(p22.3;q23.3); MLLT3-KMT2A | Fibroblast Growth Factor Basic Form Measurement | FLT3 Internal Tandem DuplicationUnited States
-
University of UtahActive, not recruitingNon-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor (Disorder)United States
-
Mayo ClinicCompletedEndothelial Dysfunction | Coronary Atherosclerosis | Coronary Small Vessel DiseaseUnited States
-
Oregon Health and Science UniversityRecruitingCardiovascular Diseases | Hypertension | Sleep | Cardiovascular Risk Factors | Circadian RhythmsUnited States
-
Tulane UniversityJohns Hopkins UniversityRecruitingEndothelial Dysfunction | Vascular Stiffness | Left Ventricular Dysfunction | Left Ventricular HypertrophyUnited States
-
Mayo ClinicNational Institutes of Health (NIH); National Institute on Aging (NIA)CompletedEndothelial Dysfunction | Coronary AtherosclerosisUnited States
-
Yale UniversityNatera, Inc.; Yale Cardiovascular Research GroupSuspendedEndothelial Dysfunction | Microvascular Coronary Artery Disease | Cardiac Allograft VasculopathyUnited States
-
iOMEDICO AGPfizerCompletedBreast Cancer | Hormone Receptor Positive Tumor | Human Epidermal Growth Factor 2 Negative Carcinoma of BreastGermany
-
Janssen Research & Development, LLCRecruitingUrinary Bladder Neoplasms | Receptors, Fibroblast Growth FactorKorea, Republic of, United States, Germany, Spain, Netherlands
-
Astellas Pharma Global Development, Inc.TerminatedNon-small Cell Lung Cancer (NSCLC) | Epidermal Growth Factor Receptor (EGFR) MutationsUnited States
-
University of EdinburghBritish Heart FoundationCompletedCoronary Artery Disease | Coronary Angiography | Vascular Injury | Endothelial Progenitor CellsUnited Kingdom
-
Mayo ClinicGlaxoSmithKlineCompletedEndothelial Dysfunction | Coronary Atherosclerosis | Coronary Small Vessel DiseaseUnited States
-
Wake Forest University Health SciencesTerminatedFuchs Dystrophy | Cystoid Macular EdemaUnited States
-
Merck KGaA, Darmstadt, GermanyCompletedEpidermal Growth Factor Receptor (EGFR) Expressing Metastatic Colorectal CancerSweden, Australia, Brazil, Bulgaria, France, Italy, Korea, Republic of, Russian Federation, South Africa, Spain, Turkey, United Kingdom, Germany, Hungary, Poland, Romania, Austria, Belgium, Finland, Netherlands, Slovakia, Greece, Ta... and more
-
Massachusetts General HospitalCompletedPulmonary Hypertension | Nitric Oxide | Blood Transfusion | Endothelial PhysiopathologyUnited States
-
University of California, San FranciscoEnrolling by invitationStroke | Vasculitis | Aneurysm | Tumor Necrosis Factor-alphaUnited States
-
University of ArizonaNational Cancer Institute (NCI); GlaxoSmithKlineTerminatedMale Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-positive Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of BreastUnited States
-
Indiana University School of MedicineAbbottCompletedInflammation | Hypertension | Chronic Kidney Disease | Endothelial DysfunctionUnited States
-
Brigham and Women's HospitalNational Institutes of Health (NIH)CompletedDiabetes Mellitus | Albuminuria | Endothelial DysfunctionUnited States
-
University of Texas at AustinPOM Wonderful LLCCompletedSarcopenia | Cardiovascular Risk FactorUnited States
-
Wake Forest University Health SciencesCompletedCardiovascular Diseases | Hypertension | Blood Pressure | Cardiovascular Risk Factor | Autonomic Nervous System ImbalanceUnited States
-
Hoffmann-La RocheTerminatedEstrogen Receptor-positive (ER+)/Human Epidermal Growth Factor Receptor (HER2)-Negative Locally Advanced or Metastatic Breast CancerCanada, United States, United Kingdom, Australia, Germany
-
Astellas Pharma Global Development, Inc.CompletedNon-Small-Cell Lung Cancer (NSCLC) | Epidermal Growth Factor Receptor MutationsUnited States
-
Brigham and Women's HospitalJichi Medical University; Shin Koga Hospital; Kokura Memorial Hospital; Shonan... and other collaboratorsUnknownAcute Coronary Syndrome | Percutaneous Coronary Intervention | Coronary Atherosclerosis | Endothelial Shear Stress | Arterial RemodelingUnited States
-
Novartis PharmaceuticalsCompletedMetabolic Syndrome | Insulin Resistance | Endothelial Dysfunction | High Blood PressureUnited States